3[1]Barbara E. Murray. Vancomycin resistant enterococcal infections. N Engl J Med,2000,342(10) :710-721
4[2]Fontana R, Ligozzi M, Pittaluga F, et al. Intrinsic penicillin resistance in enterococci. Microb Drug Resist, 1996,2(2): 209-213
5[3]Rybkine T, Mainardi JL, Sougakoff W, et al. Penicillin binding protein 5 sequence alterations in clinical isolates of Enterococcus faecium with different levels of β Lactamase resistance .J Omfect Dis, 1998,178( 1 ): 159-163
6[4]Mevius D, Devriese L, Butaye P, et al. Isolation of glycopeptide resistant Streptococcus gallolytixus strains with vanA, vanB, and both vanA and vanB genotypes from faecal samples of veal calves in the Netherlands. J Antimicrob Chemother, 1998,42 (2): 275-276
7[5]Van der Auwera P, Pensart N, Korten V, et al. Influence of oral glycopeptides on the fecal flora of human volunteers: Selection of highly glycopepfide resistant enterococci. J Infect Dis, 1996,173(5): 1 129-1136
8[6]Dodge RA, Daly JS, Davaro R, et al. High dose ampicillin plus streptomycin for treatment of a patient with severe infection due to multiresistant enterococc. Clin Infect Dis, 1997,25 (5): 1269-1270
9[7]Caron F, Pestel M, Kitzis MD, et al. Comparison of different β lactamase glycopeptide gentamicin combinations for an experimental endocarditis caused by a highly β lactamase resistant and highly glycopeptide resistant isolate of Enterococcus faecium. J Infect Dis, 1995,171(1): 106-112
10[8]Brandt CM, Rouse MS, Laue NW, et al. Effective treatment of multidrug resistant enteroeoccal experimental endocarditis with combinations of cell wall active agents. J Infect Dis, 1996,173(4):909-913
